MPAnalytics Elects Dr. Edward Wright to Board of Directors
Chapel Hill, NC — January 25, 2010 — MPAnalytics, Inc., a consulting group providing evaluation of commercial potential for medical devices and technologies, has elected Dr. Edward Wright, Associate Professor of Global Management and Strategy at Western Carolina University and CEO of Keller-Wright, LLC., to their Board of Directors.
“I am delighted to join the Board of Directors for MPAnalytics,” states Dr. Wright. “MPA is an exciting company providing highly-valuable analyses of the commercial feasibility of new medical product ideas. They also help businesses with advice regarding reimbursement, FDA approval, and clinical trial protocols. Dr. Blair Keagy and his colleagues are deeply experienced, pragmatic, and leading experts in several medical field categories.”
Dr. Wright is a North Carolina native, a graduate of the University of North Carolina, and a past senior executive in the global medical device industry. He has more than 20 years of leadership experience in the design, development and commercialization of advanced medical technologies. Currently, Dr. Wright serves as an industry advisor with the joint UNC – NC State University Bio-Medical Engineering Program.
“We are extremely pleased to have Dr. Wright join our company,” Dr. Keagy states. “He brings a tremendous wealth of industry experience as well as a true understanding of the objectives we would like to achieve in the coming years.”
About MPAnalytics, Inc.
MPAnalytics provides market analysis and recommendations for new medical devices and technology based on five key parameters: scientific merit, reimbursement potential, competition and clinical potential, practical market potential and clinical trial analysis. The founders of MPAnalytics have extensive clinical experience as well as knowledge of clinical trial design, reimbursement issues and practical markets for new medical devices and technologies. Visit www.mpanalytics.com for more information.
About Keller-Wright, LLC
Keller-Wright is dedicated to helping businesses and business people achieve their most challenging goals. Our unique Scholar-Practitioner approach to consulting considers the latest in academic research coupled with best business practices to bring you practical, leading edge ideas and insight. Visit www.keller-wright.com for more information.
Dr. Blair Keagy Launches MPAnalytics, Inc. Medical Consultant Group
MPAnalytics, a medical consultant group, provides market analysis and guidance for new medical devices, technology, and clinical trial protocol.
Chapel Hill, NC — November 17, 2008 — Blair Keagy, MD, CEO, is pleased to announce the launch of MPAnalytics, Inc. - a medical consultant group dedicated to helping businesses evaluate the commercial potential of new medical products and technologies.
MPAnalytics provides market analysis and recommendations for new medical devices and technology based on five key parameters: scientific merit, reimbursement potential, competition and clinical potential, practical market potential and clinical trial analysis. The founders of MPAnalytics have extensive clinical experience as well as knowledge of clinical trial design, reimbursement issues and practical markets for new medical devices and technologies.
Dr. Blair Keagy, former Chief of Vascular Surgery at the University of North Carolina, has authored numerous articles as well as a textbook on healthcare economics and is considered an expert on medical reimbursement.
“I credit my colleagues at the UNC School of Medicine and the Kenan-Flaghler Launching the Venture Program with helping to get this business off the ground” states Dr. Keagy. “Now, we have clients enthusiastically soliciting our help in assessing the business potential of their new medical devices or ideas before investing significant monies in development or clinical trial.”
Ted Zoller, Executive Director, UNC Center for Entrepreneurial Studies describes MPAnalytics as “an excellent example of the type of entrepreneurial venture that we hope will emerge from our program. Blair and his team have great medical expertise. MPA’s assessment of commercial potential and their depth of market analysis are far better than the typical medical advisory board can provide.”
The MPAnalytics team combines their competence in medical research and the life sciences marketplace with the business savvy necessary to create a medical consultant group that provides great value to medical device companies and investor groups.
For more information about MPAnalytics,Inc. please contact Blair Keagy at bkeagy@mpanalytics.com or call 919.873.4047.